158 related articles for article (PubMed ID: 25177566)
21. Changes in hematological parameters post plateletpheresis: Single center study from North India.
Rajput S; Makroo RN; Chowdhry M; Thakur UK
Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
[TBL] [Abstract][Full Text] [Related]
22. Impact of changes to donor hemoglobin criteria on the rate of donor deferral.
Perez GE; Gammon RR; Whitaker BI; Vassallo RR; Stubbs JR
Transfusion; 2018 Nov; 58(11):2581-2588. PubMed ID: 30264396
[TBL] [Abstract][Full Text] [Related]
23. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
[TBL] [Abstract][Full Text] [Related]
24. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast.
Kouao MD; Dembelé B; N'Goran LK; Konaté S; Bloch E; Murphy EL; Lefrère JJ
Transfusion; 2012 Jul; 52(7 Pt 2):1602-6. PubMed ID: 22780941
[TBL] [Abstract][Full Text] [Related]
25. Blood donor deferral pattern in Iran.
Birjandi F; Gharehbaghian A; Delavari A; Rezaie N; Maghsudlu M
Arch Iran Med; 2013 Nov; 16(11):657-60. PubMed ID: 24206408
[TBL] [Abstract][Full Text] [Related]
26. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
27. Review of blood donor deferral with emphasis on donor and patient safety.
Lamba DS; Sachdev S; Hans R; Krishan Dhawan H; Sharma RR; Marwaha N
Transfus Clin Biol; 2023 Feb; 30(1):56-62. PubMed ID: 35835317
[TBL] [Abstract][Full Text] [Related]
28. To study the effect of 'Covishield' vaccination on pre-donation platelet counts of plateletpheresis donors.
Tomar A; Biswas AK; Pawar A; Dimri U; Kumar D; Baranwal AK
Hematol Transfus Cell Ther; 2023; 45(4):456-460. PubMed ID: 36273983
[TBL] [Abstract][Full Text] [Related]
29. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
30. Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments.
Das SS; Sen S; Zaman RU; Biswas RN
Indian J Hematol Blood Transfus; 2021 Jan; 37(1):134-139. PubMed ID: 33707846
[TBL] [Abstract][Full Text] [Related]
31. Blood pre-donation deferrals--a teaching hospital experience.
Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
[TBL] [Abstract][Full Text] [Related]
32. Analysis of blood donor deferral in Japan: characteristics and reasons.
Ngoma AM; Goto A; Sawamura Y; Nollet KE; Ohto H; Yasumura S
Transfus Apher Sci; 2013 Dec; 49(3):655-60. PubMed ID: 23891317
[TBL] [Abstract][Full Text] [Related]
33. A review of predonation blood donor deferrals in a university hospital.
Bashawri LA
J Family Community Med; 2005 May; 12(2):79-84. PubMed ID: 23012080
[TBL] [Abstract][Full Text] [Related]
34. Assessing the performance of a plateletpheresis unit at a tertiary-care academic medical center in Mexico: A 6-year experience.
Jaime-Pérez JC; Beltrán-López AL; Alvarado-Navarro DM; Espinoza-Mares M; Ancer-Rodríguez J; Gómez-Almaguer D
J Clin Apher; 2021 Dec; 36(6):808-814. PubMed ID: 34411330
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
[TBL] [Abstract][Full Text] [Related]
36. Recovery of Platelet Count among Apheresis Platelet Donors.
Thokala RP; Radhakrishnan K; Anandan A; Panicker VK
J Clin Diagn Res; 2016 Dec; 10(12):EC01-EC04. PubMed ID: 28208861
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
38. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
Spekman MLC; Ramondt S; Sweegers MG
Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
[TBL] [Abstract][Full Text] [Related]
39. Frequency and reasons of donor deferral prior to blood donation process: a single centre experience.
Khurram S; Borhany M; Anwar N; Naseer I; Boota S; Mirza I; Nadeem M; Shamsi T
Transfus Med; 2017 Feb; 27(1):10-15. PubMed ID: 27730692
[TBL] [Abstract][Full Text] [Related]
40. Automated platelet collection using the latest apheresis devices in an Indian setting.
Agarwal P; Verma A
Transfus Apher Sci; 2009 Oct; 41(2):135-8. PubMed ID: 19709930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
